Comparisons•6 min read•Updated 2025-05-22

    Henry Meds Tirzepatide Cost Without Insurance

    Henry Meds Tirzepatide Cost Without Insurance Compare cost, access, support, and fit before choosing a provider.

    Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Henry Meds Tirzepatide Cost Without Insurance Compare cost, access, support, and fit before choosing a provider.

    Quick links: semaglutide diet plan, tirzepatide diet guide, semaglutide cost guide.

    Related Resources

    For more information, explore these related guides: Trimi pricing, tirzepatide treatment, semaglutide treatment, cheapest tirzepatide provider, cheapest semaglutide provider. Readers weighing Henry Meds against the broader market should also review our cheapest-legal-GLP-1 cornerstone covering Hims, Ro, Found, Mochi, Henry Meds, LillyDirect with 503A pharmacy compliance citations.

    Frequently Asked Questions

    How does Henry compare to Trimi for weight loss?

    The best choice depends on what you value most: pricing clarity, medication options, clinician support, speed, and how simple the treatment process feels. This comparison covers the full care-path experience, not just medication selection.

    Which is more affordable, Henry or Trimi?

    Pricing comparison should go beyond headline numbers. Compare how understandable the total cost is, what is included in the monthly price, how dose changes affect cost, and whether there are hidden fees. Pricing clarity is often more important than the lowest visible number.

    What should I compare between weight loss telehealth providers?

    Compare pricing transparency, medication access and options, support model and communication quality, refill flow and convenience, switching friction if you need to change, and who each service is designed to serve best. These practical factors matter more than brand reputation alone.

    Who might prefer Henry for weight loss?

    Some readers may prefer Henry if they already trust the brand, prefer its specific program structure, or feel comfortable with its intake and delivery model. Henry has its own strengths in the weight loss telehealth space.

    Who might prefer Trimi for weight loss?

    Some readers may prefer Trimi if they want clearer treatment-specific guidance focused on GLP-1 medications, want a more direct comparison path for weight loss options, or care about pricing clarity and simpler decision support throughout the treatment journey.

    What matters most after signing up with a weight loss provider?

    The most important post-signup factors are how fast treatment starts, how easy it is to get questions answered, how refills are handled, and how dose changes are managed. These practical details often determine whether patients stay with a provider long-term.

    How do I decide which weight loss provider is right for me?

    Focus on what matters most to you: if brand familiarity and broad health services matter, consider established providers. If treatment-specific focus, pricing clarity, and direct GLP-1 guidance matter more, consider Trimi. The best provider is the one whose system fits your priorities.

    Sources & References

    1. Henry Meds
    2. Henry official website

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any weight loss treatment. Individual results vary. Both semaglutide and tirzepatide require prescriptions and should only be used under medical supervision.

    What does the published clinical evidence show for compounded tirzepatide?

    Peer-reviewed evidence: Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022). Trimi offers compounded tirzepatide starting at $125/month on the annual plan, dispensed by a 503A community sterile compounding pharmacy (BelieveRx, Texas pharmacy license #35264). Results vary by individual; eligibility is determined by a licensed clinician.

    Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively., SURMOUNT-1, NEJM 2022
    In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg., SURPASS-2, NEJM 2021
    Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo., SURMOUNT-OSA, NEJM 2024

    Key Takeaways

    • Tirzepatide 15 mg produced a mean body weight reduction of approximately 22.5% at 72 weeks in adults with obesity without diabetes; the 5 mg and 10 mg doses produced 16.0% and 21.4% reductions respectively. (Source: SURMOUNT-1, NEJM 2022)
    • In a 40-week head-to-head trial of patients with type 2 diabetes, tirzepatide 15 mg produced approximately 11.2 kg of body-weight reduction vs 5.7 kg on semaglutide 1 mg. (Source: SURPASS-2, NEJM 2021)
    • Tirzepatide reduced the apnea-hypopnea index by approximately 27 to 30 events/hour at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea, vs roughly 5 events/hour reduction on placebo. (Source: SURMOUNT-OSA, NEJM 2024)
    • Per KFF analysis (2024), commercial-plan coverage of GLP-1 medications specifically for obesity (vs type 2 diabetes) remains highly variable: approximately 19% of large employers offer GLP-1 anti-obesity coverage, often with strict BMI thresholds, prior-authorization requirements, and step-therapy mandates. (Source: KFF Issue Brief, 2024)
    • The brand finished products (Zepbound and Mounjaro) are FDA-approved and manufactured at commercial scale. Trimi's compounded tirzepatide is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility is determined by a licensed clinician who reviews your full health history, including weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea and cardiovascular disease. Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.
    TET

    Written by Trimi Editorial Team

    Trimi publishes this educational content. This byline does not imply a clinical review.

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. Quotes and source attribution are preserved.

    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.
    - Veronica L.Facebook
    It's only been 2 weeks since I've been taking the VialsRx meds from Trimi. The medication showed up pretty quickly (about 4 days after getting approval from Trimi prescriber) and I received 3 vials for my first 3 months on the subscription. For the price and convenience my take is that Trimi and VialsRx is good.

    (VialsRx is the former name of BelieveRx.)

    Editorial Standards

    Trimi publishes patient education with dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2206038
    2. Frías JP, Davies MJ, Rosenstock J, et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2107519
    3. Wadden TA, Chao AM, Machineni S, et al. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-023-02597-w
    4. Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2023.24945
    5. Malhotra A, Grunstein RR, Fietze I, et al. (2024). Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2404881
    6. U.S. Food and Drug Administration (2024). Zepbound (tirzepatide) Prescribing Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.

    Clinician-reviewed guide to tirzepatide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded tirzepatide option compares.